Close Menu
    Facebook X (Twitter) Instagram
    Trending
    • Ogor Mawtribes Gain Powerful New Rules in Upcoming Warhammer Age of Sigmar Battletome
    • Excel World Championship Goes Global as Competitors Tackle Puzzles in the Open Air
    • South East Water Ordered to Fund £30.5 Million Improvement Programme Following Major Supply Failures
    • Adobe Expands User Control Over AI Tools in Lightroom and Photoshop
    • Monitor Audio Radius Series 4G Launches With Ambitions to Redefine Compact Hi-Fi Sound
    • Anthropic to Hold White House Talks After AI Tool Suspension
    • Rayman Legends Retold Confirmed For October Release On Xbox Series X|S
    • Microsoft Tests AI Wearable Devices Designed for Office Workers
    Mediarun Search
    • Home
    • Top News
    • World
    • Economy
    • Science
    • Technology
    • Sport
    • Entertainment
    • Contact Us
    Mediarun Search
    Home»World»A seated patient recovering from COVID-19 after receiving the Pfizer vaccine; Understanding – International
    World

    A seated patient recovering from COVID-19 after receiving the Pfizer vaccine; Understanding – International

    Oliver AshfordBy Oliver AshfordMarch 23, 2022No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    A seated patient recovering from COVID-19 after receiving the Pfizer vaccine;  Understanding – International
    Share
    Facebook Twitter LinkedIn Pinterest Email
    Picture of manna Pfizer and gal
    The girls received two doses of the Pfizer vaccine over a 21-day period. (Photo: Social Reproduction Networks and Agência Brasil)

    A Welsh man, UK, is the first person in the world to treat COVID-19 with a preventive vaccination. For seven months, Ian Lister, 37, lived with the virus in his body. Even, in treatment with two doses of the immunomodulator from Pfizer, the girls got a negative result for the virus.

    According to an article published in the “Journal of Clinical Immunology,” this was the first time the mRNA technology in a vaccine had been used to treat persistent infection by COVID-19. Scientists are awaiting results from other patients to verify the effectiveness of the immunizing agent as a preventative measure.

    understand the issue

    Lister suffers from Wiskott-Aldrich syndrome (WAS), which causes a rare genetic immune deficiency. Once he contracted COVID-19 in the work environment, the virus remained in his body for several months.

    “Although most people were able to stop self-isolating ten days after contracting the virus, I was the exception to the rule. Months went by, and it felt like the age when you couldn’t go anywhere or see friends or family.”

    He also said the symptoms get worse the longer the virus remains in the body. This included extreme tiredness, lack of sleep, headache and chest tightness. Every positive test made me feel more frustrated and anxious.”

    The girls were accompanied by specialists from the Center for Immunodeficiency in Wales, located at Cardiff University, where doctors proposed the vaccine as a way to treat the patient from the disease.

    So Ian received two doses of the Pfizer vaccine over a 21-day period. 72 days after the first vaccination, the result of COVID-19 from the gallbladder was negative.

    See also  Controversy and doubts surrounding the discovery of the 'oldest pyramid in the world' | Sciences

    According to Professor Stephen Jules, clinical leader of the Center for Immunodeficiency Wales, the immune system causes an increase in the production of T cells, which are responsible for producing an immune response against the virus and antibodies.

    Moreover, scientist Mark Bonsford, also from Cardiff University, indicated that Lester’s body was tolerant to the Pfizer vaccine. “Ian’s response to conventional vaccines in the past has been very limited.”

    Read more about COVID-19

    Check other relevant information about the epidemic caused by Sars-CoV-2 virus in Brazil and the world. Texts, infographics and videos talk about symptomsAnd the preventAnd the Search And the vaccination.

    Oliver Ashford

    Oliver Ashford is a contributor to Mediarunsearch.co.uk, covering a broad range of topics including news, politics, business, technology, sport, entertainment and lifestyle. He focuses on delivering clear, balanced reporting that helps readers stay informed about current affairs and developments that matter. With an emphasis on accuracy, relevance and accessibility, Oliver aims to present useful information and engaging stories in a straightforward manner, making complex topics easier for readers to understand and follow.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Trump is boycotting the meeting with European leaders to contact Putin

    August 19, 2025

    Scientists depict the sea in the eye of Hurricane Irene; Examine

    August 18, 2025

    Pakistani monsoon rain leaves more than 350 people in 48 hours

    August 18, 2025
    Leave A Reply Cancel Reply

    Navigate
    • Home
    • Top News
    • World
    • Economy
    • Science
    • Technology
    • Sport
    • Entertainment
    • Contact Us
    Pages
    • About Us
    • Contact Us
    • DMCA
    • Editorial Policy
    • Privacy Policy
    © 2026 Media Run Search. All Rights Reserved. Designed by Media Run Search.

    Type above and press Enter to search. Press Esc to cancel.